A carregar...
METFORMIN USE AND RISK OF COLORECTAL ADENOMA AFTER POLYPECTOMY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
BACKGROUND: Existing literature suggests that metformin, the most commonly used biguanide, may lower colorectal cancer (CRC) risk. Because most CRCs originate in pre-cancerous adenomas, we examined whether metformin use lowered colorectal adenoma risk after polypectomy in patients with type-2 diabet...
Na minha lista:
| Publicado no: | Cancer Epidemiol Biomarkers Prev |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4633388/ https://ncbi.nlm.nih.gov/pubmed/26377195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-15-0559 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|